Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Iron Deficiency Anemia
Open-data reference.
23 US clinical trials · 5 currently recruiting
Active & Recent Trials
Intravenous Versus Oral Iron for Treating Iron-Deficiency Anemia in Pregnancy
Women and Infants Hospital of Rhode Island
NCT05462704
Darbe Plus IV Iron to Decrease Transfusions While Maintaining Iron Sufficiency in Preterm Infants
University of Washington
NCT05340465
Iron Deficiency Anemia (IDA) and the Brain
Children's Hospital Los Angeles
NCT05929729
Trial of IV vs Oral Iron Treatment of Iron Deficiency Anemia in the Post-Operative Bariatric Surgical Patient
Auerbach Hematology Oncology Associates P C
NCT04268849
A Study to Evaluate Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects
AMAG Pharmaceuticals
NCT03893045
Evaluation of Efficacy and Safety of Ferric Carboxymaltose (FCM) in Patients With Iron Deficiency Anemia and Impaired Renal Function
American Regent
NCT00981045
Ferric Citrate for the Transition From CKD Stage 4/5 to CKD Stage 5D
Denver Nephrologists, P.C.
NCT02492620
Iron Deficiency in Female State Fair Attendees
University of Minnesota
NCT03228173
2 Doses of Ferrlecit Versus Oral Iron to Treat Iron-deficiency Anemia in Peritoneal Dialysis Patients.
Watson Pharmaceuticals
NCT00223977
Incidence of Hypophosphatemia After Treatment With Iron Isomaltoside/Ferric Derisomaltose vs Ferric Carboxymaltose in Subjects With Iron Deficiency Anaemia
Pharmacosmos A/S
NCT03238911
An Extension Trial to Assess the Safety of Re-dosing of Iron Isomaltoside/Ferric Derisomaltose (Monofer®/Monoferric®)
Pharmacosmos A/S
NCT02962648
Daily vs Alternate Day Iron Supplementation for Pregnant Women With Iron Deficiency Anemia
Icahn School of Medicine at Mount Sinai
NCT03562143
Multicenter Randomized Active-controlled Study to Investigate Efficacy & Safety of IV FCM in Pediatric Patients With IDA
American Regent
NCT03523117
Iron Deficiency and FGF23 Regulation in CKD and HF
Northwestern University
NCT03106298
A Study Comparing Two Ferric Carboxymaltose Formulations in Patients With Iron Deficiency Anemia
Sandoz
NCT03399084
Total Dose Infusion of Ferumoxytol(1020mg) in 15 Minutes for Iron Deficiency Anemia
Auerbach Hematology Oncology Associates P C
NCT01374919
The Effect of H. Pylori Infection on Iron Metabolism
Seattle Institute for Biomedical and Clinical Research
NCT00202488
Pilot Study of the Effect of Iron Fortified Rice in Iron Deficient Anemic Women
Pennington Biomedical Research Center
NCT01658488
Effect of Iron Supplements on the Growth of Enteric Pathogens
Iowa State University
NCT05762380
Short-Term Effects & Safety of an Accelerated Intravenous Iron Regimen in Patients With Heart Failure
University of North Carolina, Chapel Hill
NCT01925703
Improving the Iron Status of Athletes With Pre-, Pro- and Synbiotics
King's College
NCT06021171
Efficacy and Safety of Intravenous Ferric Carboxymaltose in Pediatric Patients With Iron Deficiency Anemia and Unsatisfactory Response Oral Iron Under Study Protocol 1VIT17044
American Regent
NCT04269707
Oral Iron Versus Oral Iron Plus a Web-based Behavioral Intervention in Young Children (IRONCHILD)
Baylor College of Medicine
NCT04371536
Phase Distribution
| Phase | Trial count |
|---|---|
| Early Phase 1 | 1 |
| Phase 2 | 3 |
| Phase 3 | 10 |
| Phase 4 | 2 |
Top Sponsors
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Reading the Iron Deficiency Anemia Trial Landscape
ClinicalTrials.gov lists 23 US studies indexed under Iron Deficiency Anemia, and 5 of those are currently open to recruitment — roughly 22% of the total volume on the registry. That ratio is a useful proxy for activity level: a high share of recruiting studies often signals that research interest is current and that new enrollment opportunities are appearing, while a low share typically means the field is dominated by completed or follow-up work where most participant spots have already been filled. These counts reflect the public registry only and include studies at every stage of design, so they should be read as an index of research attention rather than as a measure of treatment availability.
The phase distribution for Iron Deficiency Anemia shows 12 late-stage studies (Phase 3 and Phase 4 combined) alongside 4 earlier-phase entries (Phase 1 through Phase 2). Phase 1 and Phase 2 studies focus on early safety signals, dosing, and preliminary effect, while Phase 3 studies are typically the larger efficacy and safety trials submitted toward regulatory review, and Phase 4 studies follow approved interventions in real-world use. A condition weighted toward later phases often reflects a mature research pipeline with several interventions already close to or past approval, whereas a heavier early-phase tilt suggests the field is still exploring new mechanisms and candidate approaches.
Top sponsor activity for Iron Deficiency Anemia is led by American Regent with 3 indexed trials, alongside 9 other organizations in the top contributor list. The list on this page surfaces up to 23 of the most relevant recent and active entries, ordered with recruiting studies first so practical options are visible. All figures are derived from the public ClinicalTrials.gov dataset maintained by the National Library of Medicine and are reproduced here for reference. Inclusion of a trial, sponsor, or intervention on this page is neither an endorsement nor a recommendation — eligibility, protocol changes, and site-level status can shift frequently, so always verify current details on ClinicalTrials.gov and consult a qualified healthcare provider before acting on anything you see here.
Frequently Asked Questions
How many clinical trials are there for Iron Deficiency Anemia?
PlainTrial tracks 23 US clinical trials for Iron Deficiency Anemia, of which 5 are currently recruiting participants. Data sourced from ClinicalTrials.gov.
How do I find a recruiting trial for Iron Deficiency Anemia?
Use the trial list above filtered by "Recruiting" status, or visit our trial finder at /recruiting to search by condition and state. Always discuss trial participation with your healthcare provider before enrolling.
Is this data current?
Data is sourced from ClinicalTrials.gov and reflects our most recent data pull. Trial status may have changed since then. Always verify current information at ClinicalTrials.gov before making decisions about participation.
Related
Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from ClinicalTrials.gov (National Library of Medicine). Consult a qualified professional before making decisions based on this data.
Read our methodology — how this data is sourced, computed, and verified.
Source: ClinicalTrials.gov (NIH/NLM) ClinicalTrials.gov AACT registry · 2024 Trial counts and statuses sourced from ClinicalTrials.gov. Sponsor counts include both industry and federal/academic sponsors.